Doxycycline, Temozolomide and Ipilimumab in Melanoma

NCT01590082 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Accrual slow due to alternate trials and treatment options.

Conditions

Melanoma

Interventions

DRUG: Doxycycline
DRUG: Ipilimumab
DRUG: Temozolomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]